P

ProQR Therapeutics NV
D

PRQR

1.54000
USD
0.00
(0.00%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
162,027,292
أصول ذات صلة
A
ARWR
-0.375
(-2.45%)
14.915 USD
B
BEAM
-0.830
(-4.60%)
17.230 USD
C
CRSP
-1.680
(-4.51%)
35.580 USD
E
EDIT
-0.12000
(-8.03%)
1.37500 USD
F
FATE
-0.03260
(-3.26%)
0.96740 USD
G
GNFT
-0.16000
(-3.80%)
4.05000 USD
N
NTLA
-0.44500
(-5.36%)
7.86500 USD
R
RARE
-0.650
(-1.84%)
34.750 USD
T
TGTX
0.030
(0.09%)
33.380 USD
المزيد
الأخبار المقالات

العنوان: ProQR Therapeutics NV

القطاع: Healthcare
الصناعة: Biotechnology
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.